@prefix this: <
http://purl.org/np/RAgNJMmLQvi4W8OsxlMWanQdU5ccGxMOYjk-55-Fuit_k
> .
@prefix sub: <
http://purl.org/np/RAgNJMmLQvi4W8OsxlMWanQdU5ccGxMOYjk-55-Fuit_k#
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix nt: <
https://w3id.org/np/o/ntemplate/
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix orcid: <
https://orcid.org/
> .
@prefix bl: <
https://w3id.org/biolink/vocab/
> .
@prefix nkg: <
https://w3id.org/um/neurodkg/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
<
http://purl.obolibrary.org/obo/DOID_7148
>
bl:category
bl:Disease
.
sub:association
rdf:object
<
http://purl.obolibrary.org/obo/DOID_7148
> ;
rdf:predicate
bl:treats
;
rdf:subject
<
https://identifiers.org/drugbank:DB01097
> ;
a
rdf:Statement
;
rdfs:label
"leflunomide is indicated in adults for the treatment of active rheumatoid arthritis ra to reduce signs and symptoms to inhibit structural damage as evidenced by x ray erosions and joint space narrowing to improve physical function see clinical studies aspirin nonsteroidal anti inflammatory agents and or low dose corticosteroids may be continued during treatment with leflunomide see precautions drug interactions nsaids warnings immunosuppression potential bone marrow suppression" ;
bl:association_type
bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation
;
bl:provided_by
<
https://w3id.org/um/NeuroDKG
> ;
bl:relation
nkg:SymptomaticReliefIndication
.
<
https://identifiers.org/drugbank:DB01097
>
bl:category
bl:Drug
.
}
sub:provenance
{
sub:assertion
prov:wasAttributedTo
orcid:0000-0002-1468-3557
.
}
sub:pubinfo
{
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
npx:hasSignature
"BHkQAPO5bQ7s5zJFEtnWJbGmgyU4IeP8NUtYozoBLJTaKVpJs/ruDtF+9PlnhaBpyliw0B8WRhF9UXGDEsbI2yljyJV9QyiS+UGMm34amK4Br2GO8cCPFNaAivtaiI7s+rr+/7aIBbULk8k2zKtAAN2EDY5Fm5J1n+lhjQS2JY0=" ;
npx:hasSignatureTarget
this:
.
this:
dct:created
"2021-06-15T17:58:27.000+02:00"^^
xsd:dateTime
;
dct:creator
orcid:0000-0002-1468-3557
;
nt:wasCreatedFromProvenanceTemplate
<
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
> ;
nt:wasCreatedFromPubinfoTemplate
<
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
> ;
nt:wasCreatedFromTemplate
<
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs
> .
}